MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0019988
Merino Laboratories Private Limited
Merino Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2 Cr
▲ 404% YoY
Net profit · FY 2025
₹13.67 Lakh
Net margin 6.8%
EBITDA · FY 2025
₹17.89 Lakh
EBITDA margin 9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹18 Lakh
No open charges
Company age
26 yrs
Est. 2000
Directors on board
5
As per MCA filings
About Merino Laboratories Private Limited
Data last updated:
Merino Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 January 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2000PTC033405. Its GSTIN is 36AAICM0424H1ZP (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Abhijeet Chowdary Ponnam Venkata and Venkata Dheeraj Ponnam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D.No. 5 – 35/8A Plot No. 8 1st Floor Prasanthi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹2 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹13.67 Lakh (net margin 6.8%) and EBITDA of ₹17.89 Lakh (EBITDA margin 9%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 45% over five years.
As per MCA filings, the company has satisfied charges of ₹18 Lakh on record.
Merino Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0019988). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24231TG2000PTC033405
Registration Number 033405
Incorporation Date 31 January 2000
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0019988
CIN history
Merino Laboratories has one previous CIN (Corporate Identification Number): U24231AP2000PTC033405. The current CIN is U24231TG2000PTC033405, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG2000PTC033405 | Current |
| U24231AP2000PTC033405 | Previous |
Key People
Abhijeet Chowdary Ponnam Venkata Director Venkata Dheeraj Ponnam Director Sreevani Velivela Director Recognitions & Rankings of Merino Laboratories
Contact details
Merino Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No. 5 – 35/8A Plot No. 8 1st Floor Prasanthi Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Merino Laboratories Private Limited, buy the company report.
Comprehensive company report
Merino Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Merino Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Merino Laboratories Private Limited, buy the company report.
Financials of Merino Laboratories Private Limited
FY 2025 filings availableMerino Laboratories Private Limited reported revenue of ₹2 Cr (up 404% YoY) for FY 2025.
Revenue · FY 2025
₹2 Cr ▲ 404%
Net profit · FY 2025
₹13.67 Lakh margin 6.8%
EBITDA · FY 2025
₹17.89 Lakh margin 9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 404%
3 years · compounded
▲ 21%
5 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▲ 241%
3 years · compounded
▲ 151%
5 years · compounded
▲ 30%
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 404% growth in the latest year. EBITDA rose 241% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9% | ||||
| Net Profit Margin | 6.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Merino Laboratories Private Limited, buy the company report.
Board of directors of Merino Laboratories Private Limited
Merino Laboratories has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhijeet Chowdary Ponnam Venkata | Director | 05 Mar 2024 | 2 Years 7 Months | Current |
| Venkata Dheeraj Ponnam | Director | 12 Jun 2024 | 2 Years 4 Months | Current |
| Sreevani Velivela | Director | 26 Dec 2022 | 3 Years 9 Months | Current |
| Vinod Reddy Vintha | Director | 26 Dec 2022 | 3 Years 9 Months | Current |
| Radha Kolla Also directs: Marc24 Smart Solutions LLP | Director | 19 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Merino Laboratories Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Additek Life Sciences Private Limited | ₹2.01 Cr (FY 2019) | 187.0% | Vadodara, Gujarat, India | |||
| Merino Laboratories Private Limitedthis company | ₹2 Cr (FY 2025) | ₹13.67 Lakh | 6.8% | 404.0% | Hyderabad, Telangana, India | |
| Tri Medix Pharma Private Limited | ₹1.99 Cr (FY 2025) | 11.0% | Chandigarh, India | |||
| Precious Lifesciences Private Limited | ₹1.99 Cr (FY 2025) | -4.0% | Bhubaneswar, Odisha, India | |||
| VS Life Care Private Limited | ₹1.99 Cr (FY 2025) | -23.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| Assurelife Healthcare Private Limited | ₹1.99 Cr (FY 2025) | 77.0% | Amritsar, Punjab, India |
To see the full peer comparison of Merino Laboratories Private Limited, buy the company report.
Auditor
Merino Laboratories Private Limited is audited by GUNDLA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUNDLA & CO | FY 2022 | 007789S |
Shareholding
The shareholding of Merino Laboratories Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Merino Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹18 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Oct 2007 | 10103764 | State Bank of Hyderabad | ₹15 Lakh | Satisfied | |
| 29 May 2001 | 90129973 | Canara Bank | ₹3 Lakh | Satisfied |
To see the full charge records of Merino Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Merino Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Merino Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Merino Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICM0424H1ZP | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Merino Laboratories Private Limited, buy the company report.
Recent activity
Merino Laboratories Private Limited has 15 board changes on record since 2011: 5 appointments and 10 cessations. The latest: Radha Kolla was appointed as Director on 19 Aug 2025.
AGM
Merino Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Radha Kolla was appointed as Director.
Ceased
Abhijeet Chowdary Ponnam Venkata ceased to be Director.
Filing
Merino Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Venkata Dheeraj Ponnam was appointed as Director.
Ceased
Gadde Sarojini ceased to be Director.
Appointed
Abhijeet Chowdary Ponnam Venkata was appointed as Director.
Ceased
Anil Kumar Guntha ceased to be Director.
Ceased
Radhakrishnamurthy Guntha ceased to be Director.
Appointed
Sreevani Velivela was appointed as Director.
Appointed
Vinod Reddy Vintha was appointed as Director.
Ceased
Urusa Begum Golkonda ceased to be Director.
10 earlier events are in the company report.
Frequently asked questions
Merino Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 January 2000 (26+ years old) and is registered under CIN U24231TG2000PTC033405.
Merino Laboratories has 5 current directors:
- Abhijeet Chowdary Ponnam Venkata - Director
- Venkata Dheeraj Ponnam - Director
- Sreevani Velivela - Director
- Vinod Reddy Vintha - Director
- Radha Kolla - Director
The latest financial statements of Merino Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Merino Laboratories is 36AAICM0424H1ZP, registered in Telangana.
The CIN (Corporate Identification Number) of Merino Laboratories is U24231TG2000PTC033405. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Merino Laboratories was incorporated on 31 January 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Merino Laboratories by revenue are Additek Life Sciences Private Limited, Tri Medix Pharma Private Limited, Precious Lifesciences Private Limited, VS Life Care Private Limited, Assurelife Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Radha Kolla was appointed as Director on 19 Aug 2025. Abhijeet Chowdary Ponnam Venkata ceased to be Director on 16 Aug 2025. Venkata Dheeraj Ponnam was appointed as Director on 12 Jun 2024. Merino Laboratories has 15 board changes on record in total.
Yes, Merino Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0019988).
The registered office of Merino Laboratories is at D.No. 5 – 358A Plot No. 8 1st Floor Prasanthi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Merino Laboratories operates in the pharma industry, in the drug formulation and development segment.